Lead Biotech Analyst: We expect mass vaccinations in U.S. by Spring, Summer 2021

Matthew Harrison, biotech analyst at Morgan Stanley, talks COVID-19 case projections, state reopenings and expected vaccine timelines.
05:46
Thu, May 21 20206:11 AM EST